Agenda Highlights
Follow the complete journey of a GLP-1 receptor design project in Makya, from de novo ligand redesign using 3D structure-based methods to multiparametric optimization (MPO) and synthetic feasibility assessment. This session demonstrates how Makya’s integrated approach enables scientists to go from concept to synthesizable molecules efficiently, accelerating the transition from in silico design to the lab.
Speaker
Stefani Gamboa
Application Scientist, Iktos
Stefani Gamboa is a pharmaceutical and computational chemist by training. She holds a degree in Pharmaceutical Chemistry and a PhD in theoretical and bioinorganic chemistry, with a focus on quantum bioinorganic systems. Her doctoral research centered on the experimental design and theoretical modeling of polynuclear copper complexes, serving as bioinspired models for copper-containing enzymes with applications in catalysis and magnetic materials. Stefani gained industry experience at GlaxoSmithKline before moving into her current role as an Application Scientist at Iktos, where she works at the intersection of drug discovery, generative AI, and computational chemistry.
